DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20180882

HELLP syndrome and its implications on maternal and perinatal outcome

Amrit Pal Kaur, Navdeep Kaur, S. P. S. Dhillon

Abstract


Background: The HELLP syndrome is characterized by hemolysis (H), elevated liver enzymes (EL) and low platelet count (LP). This syndrome in general complicates 0.2-0.6% of all pregnancies but its incidence increases to 4-12% in severe preeclampsia. In about 15% cases, HELLP syndrome presents without definitive criteria for preeclampsia (atypical preeclampsia). This present study will throw light on incidence, clinical and biochemical profile of patients with HELLP syndrome and maternal and perinatal outcome.

Methods: A prospective study was conducted in the department of Obstetrics and Gynecology, Bebe Nanki Mother and Child Care Centre, Amritsar, India from January 2016 to August 2017 after approval from institutional ethics committee.

Results: In the present study, total 2949 antenatal admissions were there during the course of study. Out of these patients, 352 patients had preeclampsia-eclampsia (11.93%). Out of these 352 patients, 71 complicated with HELLP syndrome (20.17%). 17.9% had partial HELLP and 2.3% had complete HELLP syndrome. 30.16% had only EL, 31.75% had only LP, 87.3% had elevated LDH (depicted hemolysis). 4.76% had both EL and LP, 30.16% had both EL and elevated LDH, 20.63% had both LP and elevated LDH levels. Majority of the patients presented after 36 weeks of gestation. Only 5 patients had HELLP syndrome in the postpartum period. Among partial HELLP patients, 59.02% delivered vaginally and 40.98% delivered by LSCS and among complete HELLP patients 28.6% delivered vaginally and 71.4% delivered by LSCS. Perinatal mortality rate was 43.7%. Severe maternal complications such as PPH, DIC, abruptio placentae, pulmonary edema and renal failure were seen high among HELLP patients.

Conclusions: As the incidence is very high, one must be aware of its clinical and laboratory findings so that early diagnosis and treatment can be initiated. Close surveillance of the mother should be continued even after delivery.


Keywords


EL, HELLP syndrome, LP, LDH, Preeclampsia

Full Text:

PDF

References


Weinstein L. Syndrome of hemolysis, elevated liver enzymes and low platelet count; a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol. 1982;142(2):159-67.

Magann EF, Martin JN Jr: Twelve steps to optimal management of HELLP syndrome. Clin Obstet Gynecol. 1999;42:532-50.

Martin JN Jr, Rose CH, Briery CM. Understanding and managing HELLP syndrome: the integral role of aggressive glucocorticoids for mother and child. Am J Obstet Gynecol. 2006;195:914-34.

Sibai BM. Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol. 2004;103:981-91.

Geary M. The HELLP Syndrome. Br J Obstet Gynecol. 1997;104:887-91.

Sibai BM, Taslimi MW, El-Nazer A, Amon E, Mabie BG, Regan GM. Maternal- perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes and low platelets in severe preeclampsia-eclampsia. Am J Obstet Gynecol. 1986;155(3):501-8.

Sibai BM. The HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): much ado about nothing? Am J Obstet Gynecol. 1990;162:311-6.

Bansal V, Damania KR. Hypertensive Disorders in Pregnancy. In: Bhide A, Arulkumaran S, Damania K, Daftary SN. Arias’ Practical guide to high-risk pregnancy and delivery. 4th ed. Elsevier;2015:185-232.

Pritchard JA, Weisman Jr R, Ratnoff OD, Vosburgh GJ. Intravascular hemolysis, thrombocytopenia and other hematologic abnormalities associated with severe toxemia of pregnancy. N Engl J Med. 1954;250:89-98.

Bang NO, Satia MN, Poonia S. Obstetric and neonatal outcome in pregnancies complicated by hemolysis elevated liver enzymes low platelet count syndrome at a tertiary care centre in India. Int J Reprod Contracept Obstet Gynecol. 2017;5(7):2407-12.

Boopathi A, Kushtagi P. HELLP syndrome in a Government District Hospital on the west coast in South India. Int J Biomed Res. 2014;5(7):439-42.

Rose J, Arrm M, Dominic M, Mohammad AS. Maternal and perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes and low platelets in preeclampsia/eclampsia. J Obstet Gynecol Ind. 2004;54(2):147-50.

Kaur AP, Saini AS, Dhillon SPS. HELLP syndrome associated with moderate to severe preeclampsia-eclampsia. J Obstet Gynecol India.2003;53(2):165-9.

Chawla S, Marwaha A, Agarwal R. HELLP OR help: a real challenge. J Obstet Gynecol India 2015;65(3):172-5.

Osmanagaoglu MA, Osmanagaoglu S, Ulusoy H. Bozkaya H. Maternal outcome in HELLP syndrome requiring intensive care management in a Turkish hospital. Sao Paulo Med J. 2006;124:85-9.

Rakshit A, Lahiri S, Biswas SC, Dey R, Roy BR, Saha MM. A study to detect HELLP syndrome and partial HELLP syndrome among preeclamptic mothers and their impact on fetomaternal outcome. Al Ameen J Med Sci. 2014;7(1):20-5.

Tiwari P, Bhalavi S, Nayak S, Tiwari R. A study of HELLP syndrome among cases of pre-eclampsia and eclampsia: incidence and correlation of laboratory parameters. Open Access Library J. 2015;2(9):1.